Humana Inc. (NYSE:HUM) Set to Announce Earnings on Wednesday
Humana Inc. (NYSE:HUM) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, August 2nd. Analysts expect Humana to post earnings of $3.08 per share for the quarter. Humana has set its FY17 guidance at $11.10+ EPS.
Humana (NYSE:HUM) last released its earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The company had revenue of $13.76 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same period in the prior year, the company posted $1.86 EPS. On average, analysts expect Humana to post $11.1 EPS for the current fiscal year and $12.08 EPS for the next fiscal year.
Humana Inc. (NYSE:HUM) traded down 0.18% on Thursday, reaching $233.08. 202,561 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $236.02 and its 200 day moving average is $219.72. The company has a market cap of $33.64 billion, a price-to-earnings ratio of 23.75 and a beta of 0.91. Humana Inc. has a 52 week low of $163.50 and a 52 week high of $243.74.
In other news, VP Timothy S. Huval sold 13,939 shares of the company’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $225.86, for a total transaction of $3,148,262.54. Following the transaction, the vice president now directly owns 23,639 shares of the company’s stock, valued at $5,339,104.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Bruce D. Broussard sold 118,231 shares of the company’s stock in a transaction that occurred on Thursday, May 4th. The stock was sold at an average price of $225.82, for a total value of $26,698,924.42. Following the transaction, the chief executive officer now directly owns 171,170 shares in the company, valued at $38,653,609.40. The disclosure for this sale can be found here. Insiders have sold 143,241 shares of company stock worth $32,446,903 over the last ninety days. 0.80% of the stock is owned by insiders.
Several analysts have recently weighed in on the company. Zacks Investment Research cut Humana from a “hold” rating to a “sell” rating in a report on Thursday. BidaskClub cut Humana from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Piper Jaffray Companies restated a “buy” rating and set a $246.00 price target on shares of Humana in a report on Friday, July 14th. Cowen and Company reaffirmed a “buy” rating and issued a $230.00 price objective on shares of Humana in a research note on Friday, July 14th. Finally, Bank of America Corporation lifted their price objective on Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, July 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. Humana has an average rating of “Buy” and a consensus target price of $236.00.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.